CIBC Private Wealth Group’s Ascendis Pharma A/S ASND Stock Holding History

CIBC Private Wealth Group’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$2M	Buy	9,382 +1,004	+12%	+$207K	﹤0.01%	572
2025 Q3	$1.67M	Hold	8,378	–	–	﹤0.01%	606
2025 Q2	$1.45M	Hold	8,378	–	–	﹤0.01%	608
2025 Q1	$1.15M	Hold	8,378	–	–	﹤0.01%	627
2024 Q4	$1.13M	Hold	8,378	–	–	﹤0.01%	667
2024 Q3	$1.25M	Hold	8,378	–	–	﹤0.01%	645
2024 Q2	$1.14M	Hold	8,378	–	–	﹤0.01%	639
2024 Q1	$1.27M	Buy	8,378 +2,710	+48%	+$387K	﹤0.01%	616
2023 Q4	$714K	Buy	+5,668	New	+$565K	﹤0.01%	718
2018 Q3	–	Sell	-1,000	Closed	-$67K	–	1016
2018 Q2	$67K	Hold	1,000	–	–	﹤0.01%	1100
2018 Q1	$65K	Buy	+1,000	New	+$56.2K	﹤0.01%	1099

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

CIBC Private Wealth Group's ASND Position: Q4 2025 in Review

CIBC Private Wealth Group increased its Ascendis Pharma A/S (ASND) stake by 12% in Q4 2025, buying an estimated $207K and bringing the position to 9,382 shares worth $2M. The position accounts for ﹤0.01% of the portfolio, ranked #572.

CIBC Private Wealth Group first reported a position in ASND in Q1 2018 and has held it in 11 quarters since. 302 funds tracked by Wall St. Rank hold ASND as of Q4 2025.

CIBC Private Wealth Group held 9,382 shares of Ascendis Pharma A/S worth $2M as of Q4 2025.
CIBC Private Wealth Group bought 1,004 Ascendis Pharma A/S shares in Q4 2025, an estimated $207K.
Ascendis Pharma A/S made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #572 holding.
CIBC Private Wealth Group first reported a position in Ascendis Pharma A/S in Q1 2018 and has held it in 11 quarters since.
302 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.